The p75 neurotrophin receptor appears in plasma in diabetic rats - Characterisation of a potential early test for neuropathy

Diabetologia

Volumn 47, Issue 11, 2004, Pages 1924-1930

  Chilton, L ^a   Middlemas, A ^a   Gardiner, N ^a   Tomlinson, D R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Nerve growth factor; Neuropathy; Neurotrophins; p75NTR; Plasma marker; Rats; Receptor shedding

Indexed keywords

FIDARESTAT; INSULIN; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN RECEPTOR; PROTEIN P75; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; GENETIC CODE; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MALE; NERVE CRUSH; NONHUMAN; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; RAT; SCIATIC NERVE; STANDARD; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTOR, NERVE GROWTH FACTOR; REFERENCE VALUES;

EID: 12144271804     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1550-0     Document Type: Article

References (33)

1. Chen TC, Hinton DR, Sippy BD, Hofman FM (1997) Soluble TNF-alpha receptors are constitutively shed and down-regulate adhesion molecule expression in malignant gliomas. J Neuropathol Exp Neurol 56:541-550
2. Pellegrini JD, Puyana JC, Lapchak PH, Kodys K, Miller-Graziano CL (1996) A membrane TNF-alpha/TNFR ratio con-elates to MODS score and mortality. Shock 6:389-396
3. Alaaeddine N, DiBattista JA, Pelletier JP et al. (1997) Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J Rheumatol 24:1985-1994
4. Sippy BD, Hofman FM, Wright AD, He S, Ryan SJ, Hinton DR (1996) Soluble tumor necrosis factor receptors are present in human vitreous and shed by retinal pigment epithelial cells. Exp Eye Res 63:311-317
5. Levine SJ, Logun C, Chopra DP, Rhim JS, Shelhamer JH (1996) Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55 kDa TNF receptor from human airway epithelial cells. Am J Respir Cell Mol Biol 14:254-261
6. Hommes DW, Meenan J, de Haas M et al. (1996) Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. Gut 38:564-567
7. Nielsen OH, Ciardelli T, Wu Z, Langholz E, Kirman I (1995) Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. Am J Gastroenterol 90:1301-1306
8. Sadouk MB, Pelletier JP, Tardif G, Kiansa K, Cloutier JM, Martel-Pelletier J (1995) Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Lab Invest 73:347-355
9. Chen A, Engel P, Tedder TF (1995) Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J Exp Med 182:519-530
10. Rebuck N, Gibson A, Finn A (1995) Neutrophil adhesion molecules in term and premature infants: normal or enhanced leucocyte integrins but defective L-selectin expression and shedding. Clin Exp Immunol 101:183-189
11. Goebeler M, Kaufmann D, Brocker EB, Klein CE (1996) Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci 109:1957-1964
12. Chao MV, Hempstead BL (1995) p75 and Trk: a two-receptor system. Trends Neurosci 18:321-326
13. DiStefano PS, Johnson EM Jr (1988) Identification of a truncated form of the nerve growth factor receptor. Proc Natl Acad Sci USA 85:270-274
14. Hruska RE, Chertack MM, Kravis D (1993) Elevation of nerve growth factor receptor-truncated in the urine of patients with diabetic neuropathy. Ann NY Acad Sci 679:349-351
15. Lee K-F, Li E, Huber LJ et al. (1992) Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69:737-749
16. Bergmann I, Priestley JV, McMahon SB, Brocker EB, Toyka KV, Koltzenburg M (1997) Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75. Eur J Neurosci 9:18-28
17. Von Schack D, Casademunt E, Schweigreiter R, Meyer M, Bibel M, Dechant G (2001) Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system. Nat Neurosci 4:977-978
18. Oates PJ (2002) Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol 50:325-392
19. Tomlinson DR, Holmes PR, Mayer JH (1982) Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett 31:189-193
20. Santiago JV, Sönksen PH, Boulton AJ et al. (1993) Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group. J Diabet Complications 7:170-178
21. Huang EJ, Reichardt LF (2003) TRK receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642
22. Friedman WJ, Greene LA (1999) Neurotrophin signaling via Trks and p75. Exp Cell Res 253:131-142
23. Frade JM, Barde YA (1998) Nerve growth factor: two receptors, multiple functions. BioEssays 20:137-145
24. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR (1995) Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 7:1107-1110
25. Tomlinson DR, Fernyhough P, Diemel LT (1996) Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci 351:455-462
26. Fernyhough P, Diemel LT, Tomlinson DR (1998) Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 41:300-306
27. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Schatteman GC, Bothwell M (1993) Nerve growth factor receptor expression in fetal, mature, and diseased human kidneys. Lab Invest 69:703-713
28. Walch ET, Marchetti D (1999) Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells. Clin Exp Metastasis 17:307-314
29. Sortino MA, Condorelli F, Vancheri C et al. (2000) Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors. Mol Endocrinol 14:124-136
30. Weeraratna AT, Arnold JT, George DJ, DeMarzo A, Isaacs JT (2000) Rational basis for trk inhibition therapy for prostate cancer. Prostate 45:140-148
31. Conti G, Stoll G, Scarpini E et al. (1997) p75 neurotrophin receptor induction and macrophage infiltration in peripheral nerve during experimental diabetic neuropathy: possible relevance on regeneration. Exp Neurol 146:206-211
32. NGFR in human diabetic neuropathy. J Neurol Sci 135:55-62
33. Bradley JL, Thomas PK, King RH et al. (1995) Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathol (Berl) 90:403-410